newsfilter
← Latest News
GlobeNewswire·

Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference

WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases,